Literature DB >> 10428494

Transcriptional regulation of leptin gene promoter in rat.

H Fukuda1, N Iritani.   

Abstract

To investigate the DNA regulatory sequences required for stimulation and suppression of leptin gene expression, primary cultured hepatocytes and adipocytes of rats were transfected with plasmids containing the 5'-flanking sequences of the rat leptin gene fused to the luciferase gene. When two copies of the sequences spanning nucleotides -101 to -83 of the leptin promoter were used for transfection, the reporter activity significantly increased in the presence of glucose/insulin in comparison with glucose alone. The glucose/insulin stimulation of the transcription was inhibited by addition of polyunsaturated fatty acids. These results were similar to those found earlier for the transcription of the fatty acid synthase, FAS(-57/-35) and ATP citrate-lyase, ACL(-64/-41) genes. Cotransfection studies in the cells with a Sp1 expression vector and leptin (-101/-83) constructs showed the inactivation of the leptin promoter by Sp1. Gel mobility shift assays using an end-labeled leptin (-101/-83) construct as a probe revealed that nuclear factor(s) from rat liver or adipose tissue specifically formed complexes with the sequence. The DNA-protein complexes were common to the glucose/insulin-responsive regions of the leptin, ACL and FAS genes, suggesting that these genes are coordinately regulated. In addition, by antibody supershift assays, the transcription factor Sp1 was found to bind the GC-rich region located between nucleotides -101 and -83 of the leptin gene. Mutational analysis of this region showed that the sequence of the region was critical for glucose/insulin stimulation of transcription. Thus, we postulated that the region from -101 to -83 of the leptin gene is responsible for glucose/insulin stimulation of transcription, and that Sp1 is somehow involved in this regulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428494     DOI: 10.1016/s0014-5793(99)00877-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Modulation of leptin levels by oxidized linoleic acid: a connection to atherosclerosis?

Authors:  Meera Penumetcha; Nadya Merchant; Sampath Parthasarathy
Journal:  J Med Food       Date:  2010-12-27       Impact factor: 2.786

2.  Mutation in the Sp1 motif of the bovine leptin gene affects its expression.

Authors:  Tatiana Adamowicz; Krzysztof Flisikowski; Rafał Starzyński; Lech Zwierzchowski; Marek Switoński
Journal:  Mamm Genome       Date:  2006-01-13       Impact factor: 2.957

3.  Regulation of the ClC-2 lung epithelial chloride channel by glycosylation of SP1.

Authors:  Neeraj Vij; Pamela L Zeitlin
Journal:  Am J Respir Cell Mol Biol       Date:  2006-02-02       Impact factor: 6.914

Review 4.  Emerging role of leptin in rheumatoid arthritis.

Authors:  G Tian; J-N Liang; Z-Y Wang; D Zhou
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

5.  Effects of arachidonic acid on leptin secretion and expression in primary cultured rat adipocytes.

Authors:  P Pérez-Matute; A Marti; J A Martínez; M J Moreno-Aliaga
Journal:  J Physiol Biochem       Date:  2003-09       Impact factor: 4.158

6.  Sp1 is required for glucose-induced transcriptional regulation of mouse vesicular glutamate transporter 2 gene.

Authors:  Tao Li; Liqun Bai; Jing Li; Suzu Igarashi; Fayez K Ghishan
Journal:  Gastroenterology       Date:  2008-02-29       Impact factor: 22.682

7.  KLF15 Is a transcriptional regulator of the human 17beta-hydroxysteroid dehydrogenase type 5 gene. A potential link between regulation of testosterone production and fat stores in women.

Authors:  Xiaofei Du; Robert L Rosenfield; Kenan Qin
Journal:  J Clin Endocrinol Metab       Date:  2009-04-14       Impact factor: 5.958

Review 8.  Regulatory Mechanisms of Somatostatin Expression.

Authors:  Emmanuel Ampofo; Lisa Nalbach; Michael D Menger; Matthias W Laschke
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.